Company / Debt per Share
Outlook Therapeutics, Inc. Debt per Share History
FY2016-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.12
FY2019
5-year range
$0.01 / $0.12
FY2016-FY2019
Trend
+1702.3%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Debt per Share changed +1702% YoY in FY2019, a notable deviation from the 3-year average annual change of +535%.
Based on SEC 10-K filings.
0.12 in FY2019 with a 3-year CAGR of -20.4%.
Increased from $0.01 to $0.12 over the past 2 years.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -20.4%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, debt per share increased 1702.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -13.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2020 | - | - |
| FY2019 | $0.12 | +1702.3% |
| FY2018 | $0.01 | -0.2% |
| FY2017 | $0.01 | -97.2% |
| FY2016 | $0.24 | - |
As of FY2019 · SEC 10-K · Updated Jun 28, 2026